Grant of Options

IDOX PLC 06 February 2007 IDOX plc 6th February 2007 IDOX plc ('IDOX' or the 'Company') Grant of options and directors' interests IDOX announces that yesterday, options were granted to the below-noted directors following the agreement of the terms of these options at the Board meeting on 7th December 2006. All options referred to are exercisable over ordinary shares of 1p each in the capital of the Company ('Ordinary Shares') and were granted under the terms of the IDOX plc EMI scheme ('EMI Scheme') and IDOX plc Share Option Plan ('Option Plan'). Director No. of options granted Martin Brooks, Chairman and Chief Executive Officer 4,500,000 Richard Kellett-Clarke, Finance Director 4,500,000 In the case of Martin Brooks, the options must be exercised within 12 months of ceasing to be CEO, if he remains on the Board or, if earlier, within 3 months of ceasing to be an employee of the Company. In the case of Richard Kellett-Clarke, the options must be exercised within 12 months of ceasing to be an Executive Director if he remains on the Board or, if earlier, within 3 months of ceasing to be an employee of the Company. The options to each individual were awarded in two tranches subject to the following conditions: # of options Exercise Vesting Latest exercise price/p date Tranche 1 EMI Scheme 1,538,461 6.5 When granted 31 October 2011 Option Plan 711,539 6.5 When granted 31 October 2011 Tranche 2 Option Plan 2,250,000 9.0 Quarterly over 3 yrs 31 October 2014 In addition to the share options above, Martin Brooks and Richard Kellett-Clarke hold the following interests in the share capital of the Company: Director Nature of Ordinary shares % of current Holding held issued share capital Martin Brooks Direct 186,046 0.09 Indirect 586,794 0.31 Total 772,840 0.40 Richard Kellett-Clarke Direct 600,000 0.31 For further information please contact: Martin Brooks, Chairman and CEO, IDOX plc Tel: +44 (0)870 333 7101 John McNicol, Company Secretary, IDOX plc Tel: +44 (0)141 574 1935 Matthew Hall, Noble & Company Ltd Tel: +44 (0)20 7763 2200 This information is provided by RNS The company news service from the London Stock Exchange IEIID

Companies

IDOX (IDOX)
UK 100